Thymic carcinomas are rare malignancies that in general arise in the prevascular (anterior)
mediastinum. These tumors are usually invasive, often present at advanced stages, and …

A questionnaire on biomarker testing previously used in central European countries was
extended and distributed in Western and Central European countries to the pathologists …

Highlights The working group of the Polish Respiratory Society (PTChP) developed guidelines
for diagnosis and treatment of PF-ILD. What are the main findings? A multidisciplinary …

Lung cancer has several genetic associations identified within the major histocompatibility
complex (MHC); although the basis for these associations remains elusive. Here, we analyze …

Introduction: This document presents the guidelines of the Polish Respiratory Society (PTChP,
Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary …

Primary mediastinal large B-cell lymphoma (PMBL) cells depend on the constitutive activity
of NF-κB and STAT transcription factors, which drive expression of multiple molecules …

Thymic mucoepidermoid carcinoma (MEC) is a rare tumor, and its characteristics remain to
be clarified. Here we investigated 20 cases of thymic MEC to systematically characterize its …

Background: Lymphangioleiomyomatosis (LAM) is a rare interstitial lung disease characterized
by abnormal smooth muscle-like cell (LAM cell) proliferation in the lung stroma. The …

… PAC, cisplatin 50 mg/m 2 day 1 every 21 days; doxorubicin 50 mg/m 2 day 1 every 21 days;
… /m 2 day 1 every 21 days. PN, cisplatin 75 mg/m 2 day 1 every 21 days; vinorelbine 30 mg/m …

Aims Thymic epithelial tumours (TET), including thymomas and thymic carcinomas and
thymic neuroendocrine neoplasms, are malignant neoplasms that can be associated with …